No Data
No Data
Express News | Todd Deutscha: Reiterates It Is Not Their Intention to Acquire Control Stake in AIM ImmunoTech's Shares of Common Stock
Express News | Todd Deutsch Says Excpect AIM ImmunoTech Board to Promptly Amend Bylaws in Way That Is Consistent With Fiduciary Duties
Express News | Todd Deutsch Says Significant Change in AIM ImmunoTech's Board Is Urgently Needed - SEC Filing
AIM ImmunoTech Files to Sell 11.28M Shares of Common Stock for Holders
Advyzon Investment Management (AIM) Partners With FINIAT to Provide Turnkey Trading and Portfolio Management
New integration elevates portfolio management for financial services professionalsCHICAGO--(BUSINESS WIRE)--#CRM--Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
OCALA, Fla., July 03, 2024 — AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced the next CEO Corner segment has been published on the Company's website. For the CEO C
No Data